Tenofovir Alafenamide 25 MG
2021XXYU-study
Approved small_molecule active
Quick answer
Tenofovir Alafenamide 25 MG for Chronic Hepatitis C is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Hepatitis C
- Phase
- Approved
- Modality
- small_molecule
- Status
- active